Centene (NYSE:CNC) Stock Acquired Rep. Tim Moore

Key Points

• Representative Tim Moore of North Carolina purchased shares of Centene Corporation (NYSE:CNC) valued between $15,001 and $50,000 on July 18th, as disclosed in a filing made on August 5th.
• Centene's stock is currently down 2.7%, with a 12-month low of $25.11 and high of $80.59, and the company reported a net margin of 1.15% and a year-over-year revenue increase of 22.4% despite missing EPS projections.
• Several research firms, including Cantor Fitzgerald and TD Cowen, have downgraded Centene's stock rating and substantially reduced their target prices, reflecting negative market sentiment and analyst outlook on the company.

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation NYSE: CNC. In a filing disclosed on August 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in Centene stock on July 18th.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Verizon Communications NYSE: VZ on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/21/2025.

Centene Trading Up 1.3%

CNC stock traded up $0.32 during midday trading on Friday, reaching $25.58. 11,416,944 shares of the company's stock traded hands, compared to its average volume of 8,368,974. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Corporation has a fifty-two week low of $25.08 and a fifty-two week high of $80.59. The business has a 50-day moving average price of $40.30 and a two-hundred day moving average price of $53.31. The company has a market capitalization of $12.56 billion, a P/E ratio of 6.33, a PEG ratio of 1.03 and a beta of 0.40.

Centene (NYSE:CNC - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of $0.23 by ($0.39). Centene had a return on equity of 9.57% and a net margin of 1.15%. The firm had revenue of $48.74 billion during the quarter, compared to analyst estimates of $44.71 billion. During the same quarter in the previous year, the business posted $2.42 EPS. Centene's revenue was up 22.4% compared to the same quarter last year. Equities research analysts forecast that Centene Corporation will post 6.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CNC. UBS Group dropped their target price on shares of Centene from $45.00 to $31.00 and set a "neutral" rating on the stock in a research report on Monday, July 28th. Mizuho cut their price objective on shares of Centene from $71.00 to $40.00 and set a "neutral" rating on the stock in a research report on Friday, July 11th. Robert W. Baird dropped their price objective on Centene from $68.00 to $28.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Truist Financial lowered their target price on Centene from $42.00 to $35.00 and set a "buy" rating on the stock in a report on Monday, July 28th. Finally, Cantor Fitzgerald downgraded shares of Centene from an "overweight" rating to a "neutral" rating and reduced their price target for the company from $65.00 to $38.00 in a report on Monday, July 28th. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, Centene presently has an average rating of "Hold" and an average price target of $42.20.

Insider Buying and Selling at Centene

In other Centene news, Director Theodore R. Samuels II purchased 9,000 shares of the stock in a transaction that occurred on Monday, July 28th. The shares were acquired at an average cost of $27.62 per share, with a total value of $248,580.00. Following the completion of the transaction, the director owned 32,000 shares in the company, valued at $883,840. The trade was a 39.13% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.36% of the company's stock.

Institutional Investors Weigh In On Centene

Several institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC increased its position in shares of Centene by 2.2% in the second quarter. Geode Capital Management LLC now owns 13,208,639 shares of the company's stock valued at $718,547,000 after acquiring an additional 279,637 shares during the last quarter. Invesco Ltd. raised its position in shares of Centene by 5.1% in the first quarter. Invesco Ltd. now owns 11,091,964 shares of the company's stock valued at $673,393,000 after purchasing an additional 536,508 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Centene by 42.7% during the 1st quarter. AQR Capital Management LLC now owns 11,049,494 shares of the company's stock worth $669,820,000 after buying an additional 3,306,796 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of Centene by 32.3% during the fourth quarter. Ameriprise Financial Inc. now owns 6,469,062 shares of the company's stock worth $391,854,000 after acquiring an additional 1,578,917 shares during the period. Finally, Northern Trust Corp lifted its holdings in Centene by 9.1% during the 4th quarter. Northern Trust Corp now owns 5,294,816 shares of the company's stock worth $320,760,000 after purchasing an additional 443,121 shares during the last quarter. 93.63% of the stock is owned by institutional investors.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.